DOI QR코드

DOI QR Code

Awareness of Cancer Screening During Treatment of Patients with Renal Failure: A Physician Survey in Turkey

  • Uysal-Sonmez, Ozlem (Department of Medical Oncology, Sakarya University Education and Research Hospital) ;
  • Tanriverdi, Ozgur (Department of Medical Oncology, Mugla Sitki Kocman University Education and Research Hospital) ;
  • Uyeturk, Ummugul (Department of Internal Medicine, Division of Medical Oncology, Abant Izzet Baysal University Faculty of Medicine) ;
  • Budakoglu, Isil Irem (Department of Medicine Education Gazi University Faculty of Medicine) ;
  • Kazancioglu, Rumeyza (Department of Nephrology Bezm-i Alem University Faculty of Medicine) ;
  • Turker, Ibrahim (Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Clinic of Medical Oncology) ;
  • Budakoglu, Burcin (Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Clinic of Medical Oncology) ;
  • Yalcintas-Arslan, Ulku (Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Clinic of Medical Oncology) ;
  • Oksuzoglu, Berna (Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Clinic of Medical Oncology)
  • Published : 2014.03.01

Abstract

Background: Today, survival rate of patients with chronic renal failure/hemodialysis has increased so that chronic illnesses are more likely to occur. Cancer is the main cause of morbidity and mortality in such patients. Aim: In this study, physician attitudes were examined about cancer screening in patients with renal failure. Materials and Methods: This study was done by face to face questionnaire in the $27^{th}$ National Nephrology Congress to determine if the physicians dealing with chronic renal failure, hemodialysis or renal transplanted patients, recommend cancer screening or not and the methods of screening for cervix, prostate, breast and colon cancer. Results: One hundred and fifty six physicians were included in the survey. A total of 105 (67%) participants were male and the age of responders was $48{\pm}9$ years. About 29% were specialists in nephrology, 28% internal medicine, and 5% were other areas of expertise. Some 48% of participants were hemodialysis certified general practitioners. Patients were grouped as compensated chronic renal failure, hemodialysis or renal transplanted. Of the 156 responders, 128 (82%) physicians recommended breast cancer screening and the most recommended subgroup was hemodialysis patients (15%). The most preferred methods of screening were combinations of mammography, self breast examination and physicianbreast examination. 112 (72%) physicians recommended cervix cancer screening, and the most preferred method of screening was pap-smear. Colon cancer screening was recommended by 102 (65%) physicians and prostate screening by 109 (70%) physicians. The most preferred methods of screening were fecal occult blood test and PSA plus rectal digital test, respectively. Conclusions: It is not obvious whether cancer screening in renal failure patients is different from the rest of society. There is a variety of screening methods. An answer can be found to these questions as a result of studies by a common follow-up protocol and cooperation of nephrologists and oncologists.

References

  1. Vajdic CM, McDonald SP, McCredie MR, et al (2006). Cancer incidence before and after kidney transplantation. JAMA, 296, 2823-31. https://doi.org/10.1001/jama.296.23.2823
  2. Zarychanski R, Chen Y, Bernstein CN, et al (2007). Frequency of colorectal cancer screening and the impact of family physicians on screening behavior. CMAJ, 177, 593-7. https://doi.org/10.1503/cmaj.070558
  3. LeBrun CJ, Diehl LF, Abbott KC, et al (2000). Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis, 35, 237-43. https://doi.org/10.1016/S0272-6386(00)70332-5
  4. Rosenwasser LA, McCall-Hosenfold JS, Weisman CS, et al (2013). Barriers to colorectal cancer screening among women in rural control Pennsylvania: primary care physician' perspective. Rural Remote Health, 13, 2504.
  5. Scheid DC, Hamm RM, Ramakrishnan K, et al: Oklahoma Physicians Resource/ Research Network (2013). Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/ Research Network (OKPRN) study. J Am Board Fam Med, 26, 498-507. https://doi.org/10.3122/jabfm.2013.05.120230
  6. Towler B, Irwig L, Glasziou P, et al (1998). A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ, 317, 559-65. https://doi.org/10.1136/bmj.317.7158.559
  7. Ward J, Young J, Sladden M (1998). Australian general practitioners' views and use of tests to detect early prostate cancer. Aust NZ J Public Health, 22, 374-80. https://doi.org/10.1111/j.1467-842X.1998.tb01394.x
  8. Wong G, Chapman JR, Craig JC (2008a). Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol, 3, 87-100. https://doi.org/10.2215/CJN.03320807
  9. Wong G, Howard K, Craig JC, et al (2008b). Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation, 85, 532-41. https://doi.org/10.1097/TP.0b013e3181639d35
  10. Wong G, Webster AC, Chapman JR, Craig JC (2009). Reported cancer screening practices of nephrologists: results from a national survey. Nephrol Dial Transplant, 24, 2136-43. https://doi.org/10.1093/ndt/gfp009
  11. Fischereder M (2008). Cancer in patients on dialysis and after renal transplantation. Nephrol Dial Transplant, 23, 2457-60. https://doi.org/10.1093/ndt/gfn183
  12. Adami J, Gabel H, Lindelof B, et al (2003). Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer, 89, 1221-7. https://doi.org/10.1038/sj.bjc.6601219
  13. Canfell K, Sitas F, Beral V (2006). Cervical cancer in Australia and the United Kingdom: comparsion of screening policy and uptake, and cancer incidence and mortality. Med J Aust, 185, 482-6.
  14. Estakhri R, Ghahramanzade A, Vahedi A, Nourazarian A (2013). Serum levels of CA15-3, AFP, CA19-9 and CEA tumor markers in cancer care and treatment of patients with impaired renal function on hemodialysis. Asian Pacific J Cancer Prev, 14, 1597-9. https://doi.org/10.7314/APJCP.2013.14.3.1597
  15. Gotzsche PC, Nielsen M (2006). Screening for breast cancer with mammography. Cochrane Database Syts Rev, 4, 1877.
  16. Kiberd B (2013). Colorectal cancer screening in kidney disease patients: working backwards. Nephrol Dial Transplant, 28, 774-7. https://doi.org/10.1093/ndt/gfs523
  17. Kojima Y, Takahara S, Miyake O, et al (2006). Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol, 13, 1045-8. https://doi.org/10.1111/j.1442-2042.2006.01498.x
  18. Kyllonen L, Salmela K, Pukkala E (2000). Cancer incidence in a kidney- transplanted population. Transpl Int, 13, 394-8. https://doi.org/10.1111/j.1432-2277.2000.tb02068.x

Cited by

  1. Contrasts in Practices and Perceived Barriers to Colorectal Cancer Screening by Nurses and Physicians Working in Primary Care Settings in Oman vol.31, pp.1, 2016, https://doi.org/10.1007/s13187-015-0806-3
  2. Barriers to Colorectal Cancer Screening in a Primary Care Setting in Turkey vol.42, pp.1, 2017, https://doi.org/10.1007/s10900-016-0235-1